Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: patents

June 8, 2023 Drug delivery / Pharma applications

Leading innovators in cyclodextrin drug conjugates

Cyclodextrin drug conjugates is a key innovation area in the pharmaceutical industry GlobalData’s analysis uncovers the companies at the forefront of

Continue reading

February 9, 2023 Drug delivery / Pharma applications

An overview of recent patents and future perspective based on cyclodextrin complexation

This article covers information about cyclodextrin and its various derivatives, its different manufacturing process, physicochemical properties, advantages, and recent advancements.

Continue reading

January 31, 2022 Drug delivery / Pharma applications

When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications through Network Science and Text-Mining

This review of Rincón-López et al. (2021) was published in the special issue Pharmaceutical and Biomedical Applications of Cyclodextrins and

Continue reading

August 4, 2021 Drug delivery / Pharma applications

Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries since

Continue reading

January 4, 2021 E-ducation

Statistics of cyclodextrin-related publications and patents

The CD-related literature was evaluated based on Scopus search. The number of publications continued to increase reaching 2445 paper in

Continue reading

Recent Posts

  • Cyclodextrin/Caffeic Acid Nanofibers
  • Enhancing Emulsifying Properties of HBCD with octenyl succinic anhydride
  • CD-functionalized chitosan hydrogels for pH-responsive drug delivery
  • Handbook of Cyclodextrin-Based Enabling Technologies for Overcoming the Solubility and Bioavailability Limitations of Class II, III and IV Drugs
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (419)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (800)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (226)
  • Gene delivery (22)
  • Household products (1)
  • Household products (5)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (404)
  • Other industrial use (109)
  • Pharma applications (1,193)
  • Supramolecular systems (42)
  • Uncategorized (154)

Top Posts

  • Enhancing Emulsifying Properties of HBCD with octenyl succinic anhydride
  • Cyclodextrin/Caffeic Acid Nanofibers
  • Modifying the interior cavity of cyclodextrin
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • 19th International Symposium on Macrocyclic and Supramolecular Chemistry 2025
  • Trans sodium crocetinate/cyclodextrin to increase diffusion of oxygen
  • Cyclodextrins Across the Eye-Care Spectrum
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Solventless Crosslinking of Chitosan, Xanthan, and Locust Bean Gum Networks Functionalized with β-Cyclodextrin

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...